Approval · Notice of Compliance 2741 · 1998
ATACAND: Notice of Compliance 2741
Issued November 20, 1998
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 2741
- Date
- November 20, 1998
- Company
- Astra Pharma Inc.Mississauga, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- New Active Substance (NAS)
- Therapeutic class
- Angiotensin 11 at1 receptor blocker
Products in this notice
Medicinal ingredients
- CANDESARTAN CILEXETIL 4 MG per TAB
- CANDESARTAN CILEXETIL 8 MG per TAB
- CANDESARTAN CILEXETIL 16 MG per TAB